Vinflunine

IDrugs. 2004 Sep;7(9):851-9.

Abstract

Pierre Fabre SA, in collaboration with Bristol-Myers Squibb Co, is developing vinflunine, a fluorinated vinca alkaloid, as a potential anticancer agent.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Phytogenic / adverse effects
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / metabolism
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Apoptosis / drug effects
  • Clinical Trials as Topic
  • Drug Delivery Systems
  • Endothelial Cells / drug effects
  • Humans
  • Infusions, Intravenous
  • Neoplasms / drug therapy*
  • Neovascularization, Physiologic / drug effects*
  • Vinblastine / adverse effects
  • Vinblastine / analogs & derivatives*
  • Vinblastine / chemistry
  • Vinblastine / metabolism
  • Vinblastine / therapeutic use*

Substances

  • Antineoplastic Agents, Phytogenic
  • vinflunine
  • Vinblastine